<DOC>
	<DOCNO>NCT00934427</DOCNO>
	<brief_summary>The purpose study determine Vascana , novel topical formulation nitroglycerin , effective treatment prevention symptom associate Raynaud 's Phenomenon .</brief_summary>
	<brief_title>Study Topical Formulation Treatment Prevention Raynaud 's Phenomenon Symptoms</brief_title>
	<detailed_description>Raynaud 's Phenomenon sometimes debilitate condition blood flow finger toe compromise patient expose cold stress . Current therapy Raynaud 's suboptimal associate significant side effect . In study , patient response cold temperature exposures climate-controlled room application study medication measure .</detailed_description>
	<mesh_term>Raynaud Disease</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>clinical diagnosis Raynaud 's phenomenon determine history cold sensitivity pain , numbness , and/or tingle along pallor cyanosis finger history least two Raynaud 's event typical winter day must willing apply creams finger must willing undergo cold temperature exposure must willing able stop certain medication must willing use effective contraception , applicable Raynaud 's attack require hospital clinic intervention allergy nitroglycerin topical medication ingredient history migraine chronic pain unstable medical problem could interfere study heart attack uncontrolled heart problem , hypertension , hypotension past 3 month use investigational drug past 4 week significantly abnormal laboratory test certain major surgery past 6 month skin lesion certain part finger woman pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Raynaud 's</keyword>
	<keyword>scleroderma</keyword>
	<keyword>nitroglycerin</keyword>
	<keyword>MQX-503</keyword>
	<keyword>treatment</keyword>
</DOC>